(32) demonstrated that antibody-mediated inhibition of CTLA-4 and PD-1 increased the expression of adhesion molecules on tumor endothelium via T cell–derived interferon gamma–driven mechanisms, thereby enhancing lymphocyte migration into the tumor (32). The gene discussed is PDCD1; the disease is neoplasm.